-
NAV Per Share
Exchange Traded Funds (ETF)
Type of fund
Equity
Investment category
Biotech
Sector
USA
Investor locations
29/10/2014
Inception Date
1.27 mln CAD
Total assets of the fund
0.78 %
Total Cost Ratio
NYSE Arca Biotechnology Index
Benchmark
First Trust
Provider
1.27 mln CAD
Stock class assets
4 times per year
Dividend payments
-
Replication method
-
Minimum entry threshold
-
Split
CA33742D1050
ISIN
FBT
Ticker
CEOJLS
CFI